1. Guidelines Subcommittee. 1999 World Health Organization—International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151–183.
2. Neaton JD, Grimm RH, Prineas RJ . Treatment of Mild Hypertension Study (TOMHS): final results. JAMA 1993; 270: 713–724.
3. Brown MJ et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366–372.
4. Müller FB, Laragh JH . Issues, goals and guidelines for choosing first-line and combination antihypertensive drug therapy. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Treatment. Raven Press: New York, 1990, pp 2107–2115.
5. Kaplan NM . Treatment of hypertension: drug therapy. In: Kaplan NM (ed). Clinical Hypertension. Williams & Wilkins: Baltimore, 1986, pp 180–272.